acquired

Disappointing data lead Pfizer to drop heart drug acquired as part of $11B deal
Health

Disappointing data lead Pfizer to drop heart drug acquired as part of $11B deal

  When Pfizer acquired Array Biopharma for $11.4 billion three years in the past, the main target was its FDA-approved…
Back to top button
close